- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2012 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
Number Cruncher
5:13pm
May 29, 2012
Investor sues to remove HGSI ‘poison pill’
Biotech group launched shareholder rights plan to block GSK bid
From
WORLD
May 23, 2012
Greeks pay full price for medicines
State health system runs out of cash to pay pharmacies
- Samuel Brittan Competing currencies
- Martin Jacomb We must break up the failing euro
May 23, 2012
Greek crisis gets under skin of vulnerable
Long-term drug treatments beyond reach of patients
- Samuel Brittan Competing currencies
- Martin Jacomb We must break up the failing euro
From
LEX
May 22, 2012
Global pharma: time to do drugs?
Analysts’ targets already reflect the expectation that sales and earnings growth will accelerate
May 20, 2012
AstraZeneca in experimental drugs push
Move may be funded jointly with private investors
- Public health Raised resistance
- AstraZeneca among suitors eyeing Amylin
May 20, 2012
Move to create city’s medical quarter
Calthorpe Estates submits development plan for Edgbaston area
May 17, 2012
HGSI fights GSK bid with ‘poison pill’
US-based biotech formally rejects $2.6bn takeover bid
From
WORLD
May 15, 2012
Battle against Alzheimer’s stepped up
Clinical study on drug to combat condition launched
May 15, 2012
Curb export of prescription drugs, MPs say
‘Speculators’ who sell medicines to other EU nations create shortages
From
UK
May 14, 2012
UK report clears breast implant regulator
British agency should have been more critical
From
HEALTH CARE
May 14, 2012
Bohuon clicks with Smith & Nephew
Experience was primarily in pharmaceuticals
May 14, 2012
Debate rages over HIV drug
Critics fear pre-emptive treatment will lift infection rates
Week in Review
May 11, 2012
Witty targets HGS with first hostile bid
GlaxoSmithKline chief still faces big tests for his leadership
May 9, 2012
Teva sales disappoint on chief’s exit
Costs, exchange rates and European slowdown blamed
From
WORLD
May 9, 2012
Indian drug regulator accused of malpractice
Parliamentary report alleges collusion to approve medicines
Multimedia
Eurozone crisis: how will it affect your pensions, how safe are your savings and will your mortgage rise?
Podcast
Eurozone crisis: how will it affect your pensions, how safe are your savings and will your mortgage rise?
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 Editor's Choice
In depth
Highlights
Most popular in Companies
exec-appointments.com
-
Chief Operating Officer
Financial Services
-
Chief Information Officer
The Delta Group
-
Claims Director
HomeServe
-
Chief Executive (Director General)
Office for National Statistics
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- MBA Newslines
- Today's newspaper
- FT press cuttings
- FT ePaper
- Economic calendar
Public health: Raised resistance
Cavalier use of medicines presents drug companies with a daunting task